David A. Siegel Wave Life Sciences Ltd. Transaction History

Two Sigma Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $251,412 - $371,952	-57,400 Reduced 66.67%	28,700 $143,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $304,794 - $588,924	86,100 New	86,100 $531,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $35,482 - $58,195	-11,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $57,212 - $83,304	-11,700 Reduced 50.87%	11,300 $55,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $75,145 - $99,351	-13,300 Reduced 36.64%	23,000 $153,000
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $28,050 - $60,050	-5,000 Reduced 12.11%	36,300 $204,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $288,687 - $382,438	41,300 New	41,300 $325,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.